BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37914867)

  • 1. Predictive value of persistent antibodies at 6 months for relapse in neuronal surface antibody-associated autoimmune encephalitis.
    Zhang F; Guo Y; Liu M; Shen H; Zhou H; Yi Y; Wang J
    Neurol Sci; 2024 Apr; 45(4):1599-1607. PubMed ID: 37914867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term seizure outcomes in patients with autoimmune encephalitis: A prospective observational registry study update.
    Liu X; Guo K; Lin J; Gong X; Li A; Zhou D; Hong Z
    Epilepsia; 2022 Jul; 63(7):1812-1821. PubMed ID: 35357695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: A follow-up study in East China.
    Yao L; Yue W; Xunyi W; Jianhong W; Guoxing Z; Zhen H
    J Clin Neurosci; 2019 Oct; 68():73-79. PubMed ID: 31331752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapses of Anti-NMDAR, Anti-GABABR and Anti-LGI1 Encephalitis: A Retrospective Cohort Study.
    Zhong R; Chen Q; Zhang X; Zhang H; Lin W
    Front Immunol; 2022; 13():918396. PubMed ID: 35757705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical study of autonomic dysfunction in patients with autoimmune encephalitis.
    He J; Lian Y
    Immunobiology; 2023 Sep; 228(5):152711. PubMed ID: 37543010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations.
    Zuliani L; Nosadini M; Gastaldi M; Spatola M; Iorio R; Zoccarato M; Mariotto S; De Gaspari P; Perini F; Ferrari S; Evoli A; Sartori S; Franciotta D; Giometto B
    Neurol Sci; 2019 Oct; 40(10):2017-2030. PubMed ID: 31161339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis.
    Armangue T; Spatola M; Vlagea A; Mattozzi S; Cárceles-Cordon M; Martinez-Heras E; Llufriu S; Muchart J; Erro ME; Abraira L; Moris G; Monros-Giménez L; Corral-Corral Í; Montejo C; Toledo M; Bataller L; Secondi G; Ariño H; Martínez-Hernández E; Juan M; Marcos MA; Alsina L; Saiz A; Rosenfeld MR; Graus F; Dalmau J;
    Lancet Neurol; 2018 Sep; 17(9):760-772. PubMed ID: 30049614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABA
    Shen CH; Fang GL; Yang F; Cai MT; Zheng Y; Fang W; Guo Y; Zhang YX; Ding MP
    Ann Clin Transl Neurol; 2020 Aug; 7(8):1392-1399. PubMed ID: 32710704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis.
    Ciano-Petersen NL; Robert M; Muñiz-Castrillo S; Wucher V; Klich A; Vogrig A; Villagrán García M; Farina A; Goncalves D; Picard G; Rogemond V; Joubert B; Oliver-Martos B; Serrano-Castro PJ; Maucort-Boulch D; Honnorat J
    Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37147137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune encephalitis and seizures, cerebrospinal fluid, imaging, and EEG findings: a case series.
    Elkhider H; Sharma R; Kapoor N; Vattoth S; Shihabuddin B
    Neurol Sci; 2022 Apr; 43(4):2669-2680. PubMed ID: 34564782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.
    Muñoz-Lopetegi A; Guasp M; Prades L; Martínez-Hernández E; Rosa-Justícia M; Patricio V; Armangué T; Rami L; Borràs R; Castro-Fornieles J; Compte A; Gaig C; Santamaria J; Dalmau J;
    Lancet Neurol; 2024 Mar; 23(3):256-266. PubMed ID: 38365378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF Findings in Acute NMDAR and LGI1 Antibody-Associated Autoimmune Encephalitis.
    Dürr M; Nissen G; Sühs KW; Schwenkenbecher P; Geis C; Ringelstein M; Hartung HP; Friese MA; Kaufmann M; Malter MP; Madlener M; Thaler FS; Kümpfel T; Senel M; Häusler MG; Schneider H; Bergh FT; Kellinghaus C; Zettl UK; Wandinger KP; Melzer N; Gross CC; Lange P; Dreyhaupt J; Tumani H; Leypoldt F; Lewerenz J;
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34697224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term evolution and prognostic factors of epilepsy in limbic encephalitis with LGI1 antibodies.
    Guery D; Cousyn L; Navarro V; Picard G; Rogemond V; Bani-Sadr A; Shor N; Joubert B; Muñiz-Castrillo S; Honnorat J; Rheims S
    J Neurol; 2022 Sep; 269(9):5061-5069. PubMed ID: 35595970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive LGI1 Antibodies in CSF and Relapse Relate to Worse Outcome in Anti-LGI1 Encephalitis.
    Cui LL; Boltze J; Zhang Y
    Front Immunol; 2021; 12():772096. PubMed ID: 34975858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pediatric autoimmune encephalitis associated with anti-glutamic acid decarboxylase 65 antibody: two cases report and literature review].
    Ren CH; Ren HT; Ren XT; Zhang WH; Li JW; Dai LF; Chen CH; Guan HZ; Fang F
    Zhonghua Er Ke Za Zhi; 2021 Jan; 59(1):47-52. PubMed ID: 33397004
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term seizure outcome and antiseizure medication use in autoimmune encephalitis.
    Ilyas-Feldmann M; Prüß H; Holtkamp M
    Seizure; 2021 Mar; 86():138-143. PubMed ID: 33618141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limbic encephalitis associated with anti-NH2-terminal of α-enolase antibodies: A clinical subtype of Hashimoto encephalopathy.
    Kishitani T; Matsunaga A; Ikawa M; Hayashi K; Yamamura O; Hamano T; Watanabe O; Tanaka K; Nakamoto Y; Yoneda M
    Medicine (Baltimore); 2017 Mar; 96(10):e6181. PubMed ID: 28272206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seizure Evolution and Outcome in Pediatric Autoimmune Encephalitis.
    Woo H; Shim Y; Chae JH; Kim KJ; Lim BC
    Pediatr Neurol; 2023 Feb; 139():35-42. PubMed ID: 36508881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three cases of antibody-LGI1 limbic encephalitis and review of literature.
    Bing-Lei W; Jia-Hua Z; Yan L; Zan Y; Xin B; Jian-Hua S; Hui-Juan W
    Int J Neurosci; 2019 Jul; 129(7):642-648. PubMed ID: 30112956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.